← All candidates
26 insider filings on record.
29 filings on record.
OMEROMEROS CORP
NasdaqGM · Healthcare · $1.26B
$17.34
+0.99% · Sep 16
26 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 10 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.26B
Float
69.3M
96% public
Short % float
Pro
Price / profit
10.4
Price / future profit
15.1
Price / sales
32.7
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
21 more transactions on Pro →Context
Wall St
$33.00 avg target
+90.3% vs today · 1 analyst
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q2 '26$0.10 act+$0.43
Q1 '26$0.57 act+$0.96
Q4 '25$3.14 act+$0.90
Q3 '25−$0.32 act+$0.16
Coverage
What Makes Omeros (OMER) a Strong Momentum Stock: Buy Now?Zacks · 2w agoOmeros (OMER) Just Flashed Golden Cross Signal: Do You Buy?Zacks · 3w agoOmeros (OMER) Q2 2026 Earnings Call TranscriptMotley Fool · 4w agoOmeros (OMER) Turns Profitable As Investors Ask If The Repricing Has Gone Too FarSimply Wall St. · 08-14
The file stays open
29 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice